$MDBH Cashflow Statement | Understand Stock

$MDBH

$1.81 +$0.16 (9.7%) Close

$MDBH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Unrealized loss on investment securities, net
Accretion of investments at amortized cost (U.S Treasury Bills)
Realized loss (gain) on investment securities, net from the licensed broker dealer
Stock-based compensation
Effect of deconsolidation of subsidiary
Depreciation of property and equipment
Non-cash lease expense
Deferred costs related to revenue
Accretion of deferred grant reimbursement
Dilution of deferred grant reimbursement
Gain on deconsolidation
Portion of loss from equity investment
Gain related to dilution events
Purchases of investment securities, at fair value (made by our licensed broker dealer)
Proceeds from sales of investment securities (from our licensed broker dealer)
Warrants issued as part of an investment banking deal
Income recognized from warrants received
Impairment of investment securities
Deferred revenue
Change in ROU Asset
Change in lease liability
Changes in operating assets and liabilities:
(Increase) decrease in -
Grants receivable
Accounts receivable
Related party receivables
Prepaid expenses and other current assets
Clearing deposits
Increase (decrease) in -
Accounts payable
Accrued expenses
Related party payables
Payables to customers
Payables to non-customers
Deferred grant reimbursement
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of investment securities, at amortized cost (U.S. Treasury Bills)
Proceeds from payments and maturities of investment securities, at amortized cost (U.S. Treasury Bills)
Accretion of equity investments
Deferred grant reimbursement
Purchases of property and equipment
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from initial public offering
Costs of initial public offering
Deferred costs of initial public offering
Acquisition of non-controlling interest
Net cash provided by financing activities
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR
CASH AND CASH EQUIVALENTS - END OF YEAR
Supplemental disclosures of cash flow information:
Income taxes
Non-cash investing and financing activities:
Record right-of-use asset and operating lease liability
Modification of lease - right-of-use asset and lease liability
Warrants received as part of an investment banking deal
Accretion of equity investments
Relinquishment of deferred costs of initial public offering from prior year
Investment securities, at cost less impairment, received in lieu of cash payment
Issuance of warrants to purchase Class A stock related to the initial public offering closed on September 20, 2023

Comments